Profound Medical Corp. (PROF)
NASDAQ: PROF · Real-Time Price · USD
7.25
-0.03 (-0.41%)
Dec 20, 2024, 4:00 PM EST - Market closed
Profound Medical Market Cap
Profound Medical has a market cap or net worth of $215.83 million as of December 20, 2024. Its market cap has increased by 0.99% in one year.
Market Cap
215.83M
Enterprise Value
196.19M
1-Year Change
0.99%
Ranking
Category
Stock Price
$7.25
Market Cap Chart
Since October 30, 2019, Profound Medical's market cap has increased from $113.60M to $215.83M, an increase of 89.99%. That is a compound annual growth rate of 13.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 178.80M | -1.43% |
| Dec 29, 2023 | 181.40M | -20.19% |
| Dec 30, 2022 | 227.30M | -2.53% |
| Dec 31, 2021 | 233.20M | -42.21% |
| Dec 31, 2020 | 403.50M | 210.86% |
| Dec 31, 2019 | 129.80M | 14.26% |
View and export this data all the way back to 2019.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| biote | 221.64M |
| Nautilus Biotechnology | 220.99M |
| LifeMD | 218.29M |
| Cardiff Oncology | 217.83M |
| Alpha Tau Medical | 216.76M |
| SOPHiA GENETICS | 216.59M |
| Inhibikase Therapeutics | 215.02M |
| Zentalis Pharmaceuticals | 213.80M |